Technology News and Research

RSS

Technologies for optimizing medication adherence in older adults needed

Avoiding medication-related errors and improving medication adherence among older adults could save the nation billions of dollars and save thousands of lives, according to information included in "Technologies for Optimizing Medication Use in Older Adults," a recent report produced by the non-profit Center for Technology and Aging, and available at www.techandaging.org.

21 Dec 2009

Effectiveness of VSEL stem cells in regenerative medicine demonstrated at the ASH meeting

NeoStem, Inc. (NYSE Amex: NBS), which is a leading provider of pre-disease adult stem cell collection, processing and long-term storage services, and holds the exclusive, worldwide license to VSEL(TM) technology that uses very small embryonic-like stem cells isolated from peripheral blood, announced today that five posters and two oral presentations at the prestigious American Society of Hematology (ASH) Annual Meeting in New Orleans in early December demonstrated the basic cellular mechanisms of very small embryonic-like stem cells.

21 Dec 2009

CSC completes a Series B financing round

California Stem Cell, Inc. (CSC), a leading stem cell company, announced that it has completed a Series B financing round with private investors. The financing will enable the company to support the advancement of its therapeutic products to human clinical trials, as well as the generation and distribution of its tools to aid in stem cell research and drug discovery.

21 Dec 2009

TessArae's RM-Flu test granted FDA EUA

TessArae, LLC, a privately held company, and Affymetrix Inc., (NASDAQ:AFFX) today announced that the Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to TessArae for its TessArray® Resequencing Influenza A Microarray Detection Panel for the Detection of the 2009 H1N1 Influenza A Virus (TessArray RM-Flu test) for the duration of the declaration of emergency unless revoked earlier. The declaration of emergency will expire on April 26, 2010, unless terminated earlier or renewed.

21 Dec 2009

OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva Pharmaceutical Industries

Isis Pharmaceuticals, Inc. today announced that it will receive a $10 million payment from OncoGenex Pharmaceuticals, Inc. as a result of OncoGenex' license of OGX-011 to Teva Pharmaceutical Industries Ltd. ( TEVA). OGX-011 is a second-generation antisense drug co-discovered by Isis and OncoGenex that has completed a successful Phase 2 program in patients with advanced prostate cancer and advanced non-small cell lung cancer.

21 Dec 2009

CPEX Pharmaceuticals completes enrollment in Nasulin Phase 2a clinical trial

CPEX Pharmaceuticals, Inc. today announced that the ongoing Phase 2a clinical trial of Nasulin™, the Company’s intranasal insulin candidate, has now completed enrollment. The study was initiated in February of this year and randomized 94 subjects. Results are expected at the end of the first quarter or beginning of the second quarter of 2010.

21 Dec 2009

FDA clears Dilon Diagnostics' GammaLoc lesion-localization system

Dilon Diagnostics announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its lesion-localization system for molecular imaging biopsy guidance.

21 Dec 2009

Organogenesis files a PMA with the FDA for its CelTx living cell-based technology

Organogenesis, Inc. announced today that it has filed a Premarket Approval Application (PMA) with the U.S. Food and Drug Administration (FDA) for its CelTx(TM), a living cellular construct for oral soft tissue regeneration. If approved, CelTx will be the first, living cell-based technology that is FDA-approved for use in the dental market.

21 Dec 2009

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Medicago Inc. a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.

21 Dec 2009

Seattle Genetics and GSK sign ADC collaboration agreement

Seattle Genetics, Inc., announced today that it has entered into a collaboration agreement with GlaxoSmithKline (GSK) under which GSK will pay an upfront fee of $12 million for rights to utilize Seattle Genetics’ antibody-drug conjugate (ADC) technology with multiple antigens to be named by GSK.

21 Dec 2009

Embryo biopsy does not adversely affect health of newborn singleton PGD/PGS children

The largest and longest running study of children born after preimplantation genetic diagnosis and screening has shown that embryo biopsy does not adversely affect the health of babies born as the result of a subsequent singleton pregnancy.

21 Dec 2009

Statement on Senate health care reform legislation released by Karen Ignagni

The debate before the country is not whether insurance market reforms are needed. They are. The debate is not about whether all Americans should have health care coverage. They should. The debate is about whether the current legislation can work, bend the cost curve, and be sustained.

21 Dec 2009

XSPA Profile of SAML and XSPA Profile of XACML approved as OASIS Standards for Healthcare

The OASIS international consortium today announced two new information standards that give hospitals, insurers, and others in the healthcare community much-needed mechanisms for exchanging privacy policies, evaluating consent directives, and determining authorizations.

19 Dec 2009

Medical physicists converge at ProCure TDC for training in physics of protons and proton therapy

Medical physicists from around the world converged at the ProCure Training and Development Center (TDC) last week for intense training in the physics of protons and proton therapy, an alternative to X-ray radiation for cancer treatment that spares healthy tissue and results in far fewer short- and long-term treatment side effects.

19 Dec 2009

Ontario surpasses federal target for radiation therapy

For the past 12 months, Ontario has surpassed the federal target for radiation therapy wait times, demonstrating that the province has continued to improve access to this important cancer treatment.

19 Dec 2009

NightHawk Radiology Holdings under investigation

Shareholder rights firm Robbins Umeda LLP has begun an investigation into possible mismanagement at NightHawk Radiology Holdings, Inc.. Through its subsidiaries, NightHawk provides professional services, business services, and clinical workflow technology to radiology groups and hospitals in the United States. NightHawk was founded and is headquartered in Coeur d'Alene, Idaho.

19 Dec 2009

RPC's China-based subsidiary signs strategic advisory agreement with SRA

US-based pharmaceutical company Radient Pharmaceuticals Corporation (RPC) (NYSE Amex: RPC) announced today its China-based subsidiary Jade Pharmaceutical, Inc. ("JPI"), of which RPC owns approximately 98%, has signed a strategic advisory agreement with Security Research Associates, Inc. ("SRA").

19 Dec 2009

Applied Technology Holdings opens new 25,000-square-foot facility in California

Applied Technology Holdings, Inc., today announced the opening of its new headquarters in Mission Viejo, California. The new 25,000-square-foot facility will bring employees from its MVP Sports Technologies and Applied Medical Group Subsidiaries together into one Mission Viejo neighborhood, and will enhance the collaboration between ATH's Physical Therapy, Medical, Sports, Product Design, Strategy, and Technology groups.

19 Dec 2009

Novation names OrthoScan sole supplier of Mini C-Arms

OrthoScan, Inc., a privately held medical device company based in Scottsdale, Arizona today announced that Novation, the healthcare industry's leading contracting services company, has named OrthoScan its sole supplier of Mini C-Arms.

19 Dec 2009

GE Global Ubiquitous Health Research and Development Center to be established

Incheon Free Economic Zone (IFEZ), GE Healthcare and Bio Research Complex (BRC) announced today the signing of a five year plan to invest in the establishment of the “GE Global Ubiquitous Health Research and Development Center” (GE Global u-Health R&D Center).

19 Dec 2009

Technology News and Research

Technologies for optimizing medication adherence in older adults needed

Effectiveness of VSEL stem cells in regenerative medicine demonstrated at the ASH meeting

CSC completes a Series B financing round

TessArae's RM-Flu test granted FDA EUA

OncoGenex Pharmaceuticals to pay Isis Pharmaceuticals $10M for license of OGX-011 to Teva Pharmaceutical Industries

CPEX Pharmaceuticals completes enrollment in Nasulin Phase 2a clinical trial

FDA clears Dilon Diagnostics' GammaLoc lesion-localization system

Organogenesis files a PMA with the FDA for its CelTx living cell-based technology

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Seattle Genetics and GSK sign ADC collaboration agreement

Embryo biopsy does not adversely affect health of newborn singleton PGD/PGS children

Statement on Senate health care reform legislation released by Karen Ignagni

XSPA Profile of SAML and XSPA Profile of XACML approved as OASIS Standards for Healthcare

Medical physicists converge at ProCure TDC for training in physics of protons and proton therapy

Ontario surpasses federal target for radiation therapy

NightHawk Radiology Holdings under investigation

RPC's China-based subsidiary signs strategic advisory agreement with SRA

Applied Technology Holdings opens new 25,000-square-foot facility in California

Novation names OrthoScan sole supplier of Mini C-Arms

GE Global Ubiquitous Health Research and Development Center to be established

Industry Focus eBook - Cell biology (5th edition) eBook

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News